Latin America Protein Expression Market Report and Forecast 2024-2032

Latin America Protein Expression Market Report and Forecast 2024-2032


Latin America Protein Expression Market Report and Forecast 2024-2032

Latin America Protein Expression Market Size

The global protein expression market was valued at USD 3 billion in 2023, with Latin America holding a significant market share. It is expected to grow at a CAGR of 9.8% during the forecast period of 2024-2032. The market is poised to secure a market value of USD 4.9 billion by 2032, driven by the increased protein-based research and development activities across the region.

Latin America Protein Expression Market Outlook
  • The market is anticipated to be driven by increasing technological advancements in biotechnology and product developments by researchers.
  • In June 2023, researchers from the National University of Quilmes in Argentina and the Technical University of Dresden in Germany collaborated and achieved significant breakthroughs in understanding the development of insulin in the body, focusing specifically on proteins found in the pancreas. Such research driven initiatives are likely to boost the Latin America protein expression market value in the forecast period.
  • In October 2023, São Paulo State University (UNESP) researchers developed an anti-inflammatory hydrogel based on a protein used in regulating inflammation. Such research initiatives are expected to boost the market growth.
Latin America Protein Expression Market Analysis

Protein expression is extensively used in healthcare research and development activities intended to develop modern therapeutics to combat chronic diseases such as cancer and diabetes among others. To meet the rising demand, the market is driven by high-profile collaborations contributing to the development of advanced technologies and potentially attracting investors for further partnerships. For instance, in June 2023, researchers from the National University of Quilmes in Argentina and the Technical University of Dresden in Germany collaborated and achieved significant breakthroughs in understanding how insulin is made in the body. This collaboration underscored the enhancement of Latin American expertise in biotechnology, positioning it as an emerging force in global medical research. Such research initiatives, aimed at developing a better understanding of proteins is projected to boost the Latin America protein expression market growth in the forecast period.

The protein expression market value is also impacted by increasing incidence of chronic diseases such as diabetes. In Brazil, nearly 10.25% of adults claimed to have been diagnosed with diabetes in 2023. It is estimated that diabetes will affect 11.6 million Brazilians by 2025 and Brazil is expected to become one of the top 10 diabetic countries in the world. Consequently, the market is witnessing increased development of effective therapeutics by researchers for diabetic patients. For instance, in October 2023, researchers at São Paulo State University (UNESP) developed an anti-inflammatory hydrogel based on annexin A1 (AnxA1), a protein involved in regulating inflammation in diabetic patients. The Latin America protein expression market demand is projected to be fuelled by the advent of such alternatives, which has the potential to become a groundbreaking treatment for nearly 17.7 million diabetic Brazilians. Successful application of this hydrogel in treating diabetic wounds may potentially contribute to the development of similar therapeutic products in the market. This can also be used in the development of more specialized and targeted therapies.

One of the significant Latin America protein expression market trends also include enhanced capabilities of the region in protein research and production, which can contribute to the establishment of new biotech companies and the expansion of existing ones. Thereby, increasing the availability of cutting-edge treatments in the market.

Latin America Protein Expression Market Segmentation  

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

Expression Vectors

Competent Cells

Reagents

Instruments

Services

Market Breakup by Application

Industrial

Research

Therapeutic

Market Breakup by System Type

Mammalian Cell Expression System

Yeast Cell Expression System

Insect Cell Expression System

Market Breakup by End User

Academic Research

Contract Research Organizations

Pharmaceutical and Biotechnology Companies

Market Breakup by Country

Brazil

Argentina

Mexico

Others

Market Breakup Categories

Product Expression Vectors, Competent Cells, Reagents, Instruments, Services

Application Industrial, Research, Therapeutic

System Type Mammalian Cell Expression System, Yeast Cell Expression System, Insect Cell Expression System

End User Academic Research, Contract Research Organizations, Pharmaceutical & Biotechnology Companies

Country Brazil, Argentina, Mexico, Others

Leading Players in the Latin America Protein Expression Market

The key features of the market report include grants analysis, patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows: 
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Agilent Technologies, Inc.
  • New England Biolabs.
  • Takara Bio Inc
  • Danaher Corporation
  • Promega Corporation
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. 

FAQs
  • What was the Latin America protein expression market forecast outlook for 2024-2032?
The Latin America protein expression market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 4.9 billion by 2032.
  • What are the major factors aiding the Latin America protein expression market demand?  
The market demand is driven by the increasing prevalence of chronic diseases in the region, along with rising healthcare expenditure to improve the prevailing infrastructure.
  • What are the major Latin America protein expression market trends?
The increasing efforts of researchers to develop new care solutions via protein expression utilisation is one of the market major market trends.
  • What are the various products in the market?
Various products in the market include expression vectors, competent cells, reagents, instruments, and services.
  • Where does protein expression find its applications?
Protein expression find its application in industrial, research, and therapeutic domains.
  • What is the market segmentation based on system type?
Based on system type, the market is segmented into mammalian cell expression system, yeast cell expression system, and insect cell expression system.
  • Who are the end users in the market?
End users in the market include academic research, contract research organizations, and pharmaceutical and biotechnology companies.
  • What is the market segmentation by country? 
The market segmentation by countries includes Brazil, Argentina, Mexico, and others.
  • Who are the key players in the Latin America protein expression market?
The key players in the market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Agilent Technologies, Inc., New England Biolabs., Takara Bio Inc, Danaher Corporation, Promega Corporation, QIAGEN, Bio-Rad Laboratories, Inc., and GenScript Biotech Corporation.

Meta description

The Latin America protein expression market size is poised for growth, driven by the expansion of the global market, was valued at USD 3 billion in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Protein Expression Market Overview
3.1 Latin America Protein Expression Market Historical Value (2017-2023)
3.2 Latin America Protein Expression Market Forecast Value (2024-2032)
4 Latin America Protein Expression Market Landscape*
4.1 Latin America Neonatal Ventilators: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Neonatal Ventilators: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Latin America Protein Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Protein Expression Market Segmentation (2017-2032)
6.1 Latin America Protein Expression Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Expression Vectors
6.1.3 Competent Cells
6.1.4 Reagents
6.1.5 Instruments
6.1.6 Services
6.2 Latin America Protein Expression Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Industrial
6.2.3 Research
6.2.4 Therapeutic
6.3 Latin America Protein Expression Market (2017-2032) by System Type
6.3.1 Market Overview
6.3.2 Mammalian Cell Expression System
6.3.3 Yeast Cell Expression System
6.3.4 Insect Cell Expression System
6.4 Latin America Protein Expression Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Academic Research
6.4.3 Contract Research Organizations
6.4.4 Pharmaceutical & Biotechnology Companies
6.5 Latin America Protein Expression Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Protein Expression Market (2017-2032)
7.1 Brazil Protein Expression Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Expression Vectors
7.1.3 Competent Cells
7.1.4 Reagents
7.1.5 Instruments
7.1.6 Services
7.2 Brazil Protein Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Industrial
7.2.3 Research
7.2.4 Therapeutic
7.3 Brazil Protein Expression Market (2017-2032) by System Type
7.3.1 Market Overview
7.3.2 Mammalian Cell Expression System
7.3.3 Yeast Cell Expression System
7.3.4 Insect Cell Expression System
7.4 Brazil Protein Expression Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Academic Research
7.4.3 Contract Research Organizations
7.4.4 Pharmaceutical & Biotechnology Companies
8 Argentina Protein Expression Market (2017-2032)
8.1 Argentina Protein Expression Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Expression Vectors
8.1.3 Competent Cells
8.1.4 Reagents
8.1.5 Instruments
8.1.6 Services
8.2 Argentina Protein Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Industrial
8.2.3 Research
8.2.4 Therapeutic
8.3 Argentina Protein Expression Market (2017-2032) by System Type
8.3.1 Market Overview
8.3.2 Mammalian Cell Expression System
8.3.3 Yeast Cell Expression System
8.3.4 Insect Cell Expression System
8.4 Argentina Protein Expression Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Academic Research
8.4.3 Contract Research Organizations
8.4.4 Pharmaceutical & Biotechnology Companies
9 Mexico Protein Expression Market (2017-2032)
9.1 Mexico Protein Expression Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Expression Vectors
9.1.3 Competent Cells
9.1.4 Reagents
9.1.5 Instruments
9.1.6 Services
9.2 Mexico Protein Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Industrial
9.2.3 Research
9.2.4 Therapeutic
9.3 Mexico Protein Expression Market (2017-2032) by System Type
9.3.1 Market Overview
9.3.2 Mammalian Cell Expression System
9.3.3 Yeast Cell Expression System
9.3.4 Insect Cell Expression System
9.4 Mexico Protein Expression Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Academic Research
9.4.3 Contract Research Organizations
9.4.4 Pharmaceutical & Biotechnology Companies
10 Regulatory Framework
11 Grants Analysis
11.1 Analysis by Year
11.2 Analysis by Amount Awarded
11.3 Analysis by Issuing Authority
11.4 Analysis by Grant Application
11.5 Analysis by Funding Institute
11.6 Analysis by Departments
11.7 Analysis by Recipient Organization
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Product of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Merck KGaA
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Thermo Fisher Scientific Inc.
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Lonza Group AG
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Agilent Technologies, Inc.
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 New England Biolabs.
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Takara Bio Inc.
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Danaher Corporation
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Promega Corporation
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 QIAGEN
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Bio-Rad Laboratories, Inc.
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
14.12 GenScript Biotech Corporation
14.12.1 Financial Analysis
14.12.2 Product Portfolio
14.12.3 Demographic Reach and Achievements
14.12.4 Mergers and Acquisitions
14.12.5 Certifications
15 Latin America Protein Expression Market – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings